Zinereo Pharma participated in SEMIPyP 2026, a leading event in the field of probiotics and clinical practice, where scientific updates and professional exchange are key to advancing patient management.

Beyond the scientific context, the event highlighted an increasingly relevant topic: how to integrate the microbiome into daily clinical practice. From the management of digestive disorders and functional conditions to its emerging role in women’s health and respiratory health, interest in microbiota-based solutions continues to grow exponentially in clinical settings.

Direct interaction with healthcare professionals allowed us to share real-world experiences, better understand clinical needs, and further bridge scientific evidence with medical decision-making.

This participation reinforces our vision: translating microbiome innovation into practical, effective solutions for everyday clinical use.

In the pictures, María Vallhonrat – Marketing Manager, and Antonio Amado – Business Development Manager